0
Other Articles |

THE USE OF BENZEDRINE SULFATE IN POSTENCEPHALITIC PARKINSON'S DISEASE

PHILIP SOLOMON, M.D.; ROGER S. MITCHELL, M.D.; MYRON PRINZMETAL, M.D.
JAMA. 1937;108(21):1765-1770. doi:10.1001/jama.1937.02780210005002.
Text Size: A A A
Published online

In 1933, when benzedrine (beta-phenylisopropylamine) sulfate was first used in the treatment of narcolepsy,1 it was noticed that the patients being treated not only stopped having their attacks but also reported that they tired less easily and felt more energetic in general. It was therefore thought advisable to experiment with benzedrine sulfate in conditions in which asthenia is a prominent symptom.

Twenty-eight patients with postencephalitic Parkinson's disease, ten patients with arteriosclerotic Parkinson's disease and twenty-two patients with psychoneurosis have been given benzedrine sulfate for periods varying from four weeks to sixteen months. The oldest patient in the postencephalitic group was 54, the youngest 15, with the average age 32. A history of encephalitis was definite in seventeen patients, was probable in four and could not be obtained in seven. The clinical picture was characteristic in every case, though the following signs varied from patient to patient: rigidity of the

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();